Top

International Journal of Clinical Oncology

Published in:

01-10-2010 | Case Report

A case of local advanced penile cancer treated with multimodality therapy

Authors: Manabu Kato, Norihito Soga, Kiminobu Arima, Yoshiki Sugimura

Published in: International Journal of Clinical Oncology | Issue 5/2010

Abstract

A 61-year-old man presented to our institution complaining of a putrescent left inguinal ulcerated tumor. Our diagnosis was penile cancer with bilateral inguinal lymph node metastasis and clinical staging T4N3M0. Here we report a case of local advanced penile cancer experimentally treated with a multimodal approach.

Solsona E, Algaba F, Horenblas S et al (2004) EAU guidelines on penile cancer. Eur Urol 46:1–8CrossRefPubMed

Jeremic B, Shibamoto Y, Milicic B et al (2000) Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 18(7):1458–1464PubMed

Lynch HT, Krush AJ (1969) Delay factors in detection of cancer of the penis. Nebr State Med J 54:360–367PubMed

Gursel EO, Georgountzos C, Uson AC et al (1973) Penile cancer. Urology 1:569–578CrossRefPubMed

Duncan W, Jackson SM (1972) The treatment of early cancer of the penis with megavoltage X-rays. Clin Radiol 23:246–248CrossRefPubMed

Crook J, Grimard L, Tsihlias J et al (2002) Interstitial brachytherapy for penile cancer: an alternative to amputation. J Urol 167:506–511CrossRefPubMed

Rozan R, Albuisson E, Giraud B et al (1995) Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients). Radiother Oncol 36:83–93CrossRefPubMed

Ravi R (1995) Radiation-induced carcinoma of the penis. Urol Int 54:147–149CrossRefPubMed

Kroon BK, Horenblas S, Deurloo EE et al (2005) Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int 95:517–521CrossRefPubMed

10.

Fraley EE, Zhang G, Manivel C et al (1989) The role of ilioinguinal lymphadenectomy and significance of histological differentiation in treatment of carcinoma of the penis. J Urol 142:1478–1482PubMed

11.

Nelson BA, Cookson MS, Smith JA Jr et al (2004) Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series. J Urol 172:494–497CrossRefPubMed

12.

Ornellas AA, Seixas AL, Marota A et al (1994) Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 151:1244–1249PubMed

13.

Horenblas S, van Tinteren H (1994) Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 151:1239–1243PubMed

14.

Lopes A, Bezerra AL, Serrano SV et al (2000) Iliac nodal metastases from carcinoma of the penis treated surgically. BJU Int 86:690–693CrossRefPubMed

15.

Corral DA, Sella A, Pettaway CA et al (1998) Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 160:1770–1774CrossRefPubMed

16.

Hussein AM, Benedetto P, Sridhar KS (1990) Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65:433–438CrossRefPubMed

17.

Pedrick TJ, Wheeler W, Riemenschneider H (1993) Combined modality therapy for locally advanced penile squamous cell carcinoma. Am J Clin Oncol 16:501–505CrossRefPubMed

18.

Eisenberger MA (1992) Chemotherapy for carcinomas of the penis and urethra. Urol Clin North Am 19:333–338PubMed

19.

Srinivas V, Morse MJ, Herr HW et al (1987) Penile cancer: relation of extent of nodal metastasis to survival. J Urol 137:880–882PubMed

Title: A case of local advanced penile cancer treated with multimodality therapy
Authors: Manabu Kato
Norihito Soga
Kiminobu Arima
Yoshiki Sugimura
Publication date: 01-10-2010
Publisher: Springer Japan
Published in: International Journal of Clinical Oncology / Issue 5/2010
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-010-0078-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2010

Low incidence of KIT gene mutations and no PDGFRA gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases

A false-negative sentinel lymph node in the parotid gland of a melanoma patient: a new algorithm for SLN biopsy in the parotid gland

Erratum to: Successful long-term remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic non-seminomatous germ cell tumor: an additional report to Int J Clin Oncol 2007; 12:485–487

A case of long-term recurrence-free poorly differentiated neuroendocrine carcinoma of lymph nodes treated by surgical resection without any chemotherapy

Tolerable sorafenib therapy for a renal cell carcinoma patient with hemodialysis: a case study

Metastasectomy for renal cell carcinoma as a strategy to obtain complete remission

Keynote webinar | Spotlight on antibody–drug conjugates in cancer